| Wall Street Journal. Europe 2004 Gautam Naik |
| Title | Subject | Authors |
|---|
| Adventuring with ventures: J.P. Morgan, Cazenove are latest to mull a not-quite acquisition. | Business, international | Gautam Naik, Jason Singer, Robert Sidel |
| Aventis refuses to yield to Sanofi: CEO dismisses hope for a friendly deal, plans asset split-off.(Sanofi Synthelabo SA) | Business, international | Gautam Naik, Angela Cullen |
| Aventis said "non" to Sanofi, so now it has to get tough.(Best defenses: deal isn't in drug maker's interest, or find a white knight.) | Business, international | Gautam Naik, David Gauthier-Villars |
| Aventis scrambles to find defense to takeover offer: bid is latest move in acquisitive career of Sanofi's Dehecq.(Jean-Francois Dehecq) | Business, international | Gautam Naik, John Carreyrou |
| Aventis struggles to flee clutches of smaller rival.(Sanofi-Synthelabo) | Business, international | Gautam Naik, Vanessa Fuhrmans |
| Aventis to speed sale of assets seen as noncore: move is one part of effort to repel hostile takeover by French rival Sanofi. | Business, international | Henny Sender, Gautam Naik, Robin Sidel |
| Novartis, Aventis will talk, dealing blow to Sanofi bid. | Business, international | Gautam Naik, Anita Raghavan, John Carreyrou |
| Novartis CEO goes public with pitch on Aventis deal: in unusual move, Vasella attempts to put pressure on the French government.(Daniel Vasella) | Business, international | Gautam Naik, Anita Raghavan |
| Novartis explores options on Aventis; giant Swiss drug maker weighs white knight role aimed at thwarting Sanofi.(Novartis AG, Aventis SA, Sanofi-Synthelabo SA) | Business, international | Gautam Naik, Anita Raghavan |
| Novartis talks to Aventis about white-knight offer: preliminary discussions come as French drug maker tries to fight off Sanofi bid. | Business, international | Gautam Naik, Anita Raghavan |
| Sanofi-Aventis marriage could spark merger fever. | Business, international | Gautam Naik, Jeanne Whalen |
| Sanofi is poised to unveil euro 48 billion bid for Aventis: hostile offer would create third-largest drug maker, challenging Pfizer, Glaxo.(Sanofi-Synthelabo S.A.) | Business, international | Gautam Naik, Anita Raghavan, John Carreyrou |
| Sanofi outlines plan to revamp Aventis: suitor would overhaul research and development to boost lab productivity. | Business, international | Gautam Naik, David Gauthier-Villars, Angela Cullen |
| U.N. health arm misses first goal in AIDS program: WHO calls initial results 'disappointing,' but says pace is expected to pick up.(World Health Organization) | Business, international | Gautam Naik |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
